Pieter C. Smits

Impact of chronic kidney disease and diabetes on clinical outcomes in women undergoing PCI

Spirito A, Itchhaporia D, Sartori S, Camenzind E, Chieffo A, Dangas G, Galatius S, Jeger RV, Kandzari D, Kastrati A, Kim H, Kimura T, Leon MB, Mehta LS, Mikhail G, Morice M, Nicolas J, Pileggi B, Serruys PW, Smits PC, Steg PG, Stone GW, Valgimigli M, Vogel B, von Birgelen C, Weisz G, Wijns W, Windecker S, Mehran R

August 21, 2023 | 10.4244/EIJ-D-23-00086

Evaluation of the R-One robotic system for percutaneous coronary intervention: the R-EVOLUTION study

Durand E, Sabatier R, Smits PC, Verheye S, Pereira B, Fajadet J

April 3, 2023 | 10.4244/EIJ-D-22-00642

Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial

de Winter R, Zaman A, Hara H, Gao C, Ono M, Garg S, Smits PC, Tonino P, Hofma S, Moreno R, Choudhury A, Petrov I, Cequier A, Colombo A, Kaul U, Onuma Y, Serruys PW

August 19, 2022 | 10.4244/EIJ-D-21-00766

Comparative stent trials, a never-ending story

Smits PC

June 3, 2022 | 10.4244/EIJ-E-22-00012

Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE-ABSORB randomised clinical trial

Smits PC, Chang C, Chevalier B, West N, Gori T, Barbato E, Tarantini G, Kocka V, Achenbach S, Dudek D, Escaned J, Wlodarczak A, Abdel-Wahab M, Esposito G, Tijssen J, Morice M, Onuma Y, van Geuns R

October 23, 2020 | 10.4244/EIJ-D-19-01079

Fractional flow reserve-guided multivessel angioplasty in myocardial infarction: three-year follow-up with cost benefit analysis of the Compare-Acute trial

Smits PC, Laforgia P, Abdel-Wahab M, Neumann F, Richardt G, Boxma-de Klerk B, Lunde K, Schotborgh CE, Piróth Z, Horak D, Wlodarczak A, Frederix G, Omerovic E

June 25, 2020 | 10.4244/EIJ-D-20-00012

The obesity paradox revisited: body mass index and long-term outcomes after PCI from a large pooled patient-level database

Wolny R, Maehara A, Liu Y, Zhang Z, Mintz GS, Redfors B, Madhavan M, Smits PC, von Birgelen C, Serruys PW, Mehran R, Leon MB, Stone GW

January 17, 2020 | 10.4244/EIJ-D-19-00467

Derivation and external validation of a novel risk score for prediction of 30-day mortality after percutaneous coronary intervention

Brener S, Leon MB, Serruys PW, Smits PC, von Birgelen C, Mehran R, Kirtane AJ, Witzenbichler B, Rinaldi M, Metzger C, Mazzaferri E, Zhang Z, Stone GW

August 9, 2019 | 10.4244/EIJ-D-19-00262

Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy

Asano T, Katagiri Y, Collet C, Tenekecioglu E, Miyazaki Y, Sotomi Y, Amoroso G, Aminian A, Brugaletta S, Vrolix M, Hernández-Antolín R, van de Harst P, Iñiguez A, Janssens L, Smits PC, Wykrzykowska JJ, Ribeiro V, Pereira H, da Silva P, Piek J, Reiber J, von Birgelen C, Sabaté M, Onuma Y, Serruys PW

August 3, 2018 | 10.4244/EIJ-D-17-00461

A prospective randomised trial comparing the novel ridaforolimus-eluting BioNIR stent to the zotarolimus-eluting Resolute stent: six-month angiographic and one-year clinical results of the NIREUS trial

Paradies V, Ben-Yehuda O, Jonas M, Banai S, Iñiguez A, Perlman G, Kandzari D, Stone GW, Smits PC

May 20, 2018 | 10.4244/EIJ-D-17-00890

First-in-man randomised comparison of the BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: the PIONEER trial

von Birgelen C, Asano T, Amoroso G, Aminian A, Brugaletta S, Vrolix M, Hernández-Antolín R, van de Harst P, Iñiguez A, Janssens L, Smits PC, Wykrzykowska JJ, Ribeiro V, Pereira H, da Silva P, Piek J, Onuma Y, Serruys PW, Sabaté M

April 20, 2018 | 10.4244/EIJ-D-17-00462

Everolimus-eluting bioresorbable vascular scaffolds for treatment of complex chronic total occlusions

Fam J, Ojeda S, Garbo R, Latib A, La Manna A, Vaquerizo B, Boukhris M, Vlachojannis G, van Geuns R, Ezhumalai B, Kawamoto H, van der Sijde J, Felix C, Pan M, Serdoz R, Boccuzzi G, De Paolis M, Sardella G, Mancone M, Tamburino C, Smits PC, Di Mario C, Seth A, Serra A, Colombo A, Serruys PW, Galassi A, Zijlstra F, Van Mieghem NM, Diletti R

June 20, 2017 | 10.4244/EIJ-D-16-00253

Potentially increased incidence of scaffold thrombosis in patients treated with Absorb BVS who terminated DAPT before 18 months

Felix C, Vlachojannis G, IJsselmuiden AJ, Fam J, Smits PC, Lansink W, Diletti R, Zijlstra F, Regar E, Boersma E, Onuma Y, van Geuns R

June 2, 2017 | 10.4244/EIJ-D-17-00119

Biolimus-eluting versus everolimus-eluting stents in coronary artery disease: a pooled analysis from the NEXT (NOBORI biolimus-eluting versus XIENCE/PROMUS everolimus-eluting stent) and COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) randomised trials

Vlachojannis G, Puricel S, Natsuaki M, Morimoto T, Smits PC, Kimura T

March 20, 2017 | 10.4244/EIJ-D-16-00773

Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial

Chevalier B, Onuma Y, Van Boven A, Piek J, Sabaté M, Helqvist S, Baumbach A, Smits PC, Kumar R, Wasungu L, Serruys PW

October 20, 2016 | 10.4244/EIJY16M08_01

Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with coronary artery disease: three-year follow-up of the COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) trial

Vlachojannis G, Smits PC, Hofma S, Togni M, Vázquez N, Valdes M, Voudris V, Puricel S, Slagboom T, Goy J-J, den Heijer P, van der Ent M

July 20, 2015 | 10.4244/EIJV11I3A53

Long-term follow-up of second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction: three-year results of the XAMI trial

Hofma S, Smits PC, Brouwer J, Velders M, van 't Hof A, Quere M, de Vries C, Van Boven A

March 20, 2015 | 10.4244/EIJY15M01_03

Procedural and clinical outcomes of the Absorb everolimus-eluting bioresorbable vascular scaffold: one-month results of the Bioresorbable vascular Scaffold Evaluated At Rotterdam Cardiology Hospitals (B-SEARCH)

Simsek C, Magro M, Onuma Y, Boersma E, Smits PC, Dorange C, Veldhof S, Regar E, Serruys PW, van Geuns R

June 20, 2014 | 10.4244/EIJV10I2A38

Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months

Serruys PW, Onuma Y, Garcia-Garcia H, Muramatsu T, van Geuns R, De Bruyne B, Dudek D, Thuesen L, Smits PC, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Hebert K, Rapoza R, Ormiston J

March 20, 2014 | 10.4244/EIJV9I11A217

STEMI patients and non-culprit lesions: what to do and when?

Smits PC

December 27, 2013 | 10.4244/EIJV9I8A150

Pieter C. Smits

Latest news